AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.564
-0.016 (-2.83%)
Nov 20, 2024, 4:00 PM EST - Market closed
AEON Biopharma Employees
AEON Biopharma had 10 employees as of December 31, 2023. The number of employees increased by 2 or 25.00% compared to the previous year.
Employees
10
Change (1Y)
2
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$30,552,000
Market Cap
22.27M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 10 | 2 | 25.00% |
| Dec 31, 2022 | 8 | -12 | -60.00% |
| Dec 31, 2019 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Neuronetics | 203 |
| Inspira Technologies Oxy B.H.N. | 42 |
| GlycoMimetics | 35 |
| IN8bio | 31 |
| Chemomab Therapeutics | 20 |
| Tempest Therapeutics | 17 |
| Cadrenal Therapeutics | 4 |
| MIRA Pharmaceuticals | 3 |
AEON News
- 7 days ago - AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024 - GlobeNewsWire
- 3 months ago - AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 months ago - AEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction Plan - GlobeNewsWire
- 6 months ago - AEON Biopharma Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 6 months ago - AEON Biopharma Provides Update on Development Pipeline - GlobeNewsWire
- 7 months ago - AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine - GlobeNewsWire
- 8 months ago - CORRECTION -- AEON Biopharma Announces Redemption of Public Warrants - GlobeNewsWire